Date Field | Doc. No. | Party | Description |
---|
Dec 4, 2017 | 1 | | Power of Attorney Download |
Dec 4, 2017 | 2 | | Petition for Inter Partes Review of US 9724310 Download |
Dec 13, 2017 | 3 | | Notice of Accord Filing Date Download |
Dec 13, 2017 | 4 | | Notice of Filing Date Download |
Dec 21, 2017 | 5 | | Patent Owner Mandatory Notices Download |
Dec 29, 2017 | 6 | | Petitioner's Mandatory Change-of-Information Notices Download |
Mar 13, 2018 | 7 | | Patent Owner Preliminary Response Download |
Jun 7, 2018 | 8 | | Noven Pharmaceuticals, Inc.'s First Updated Mandatory Notice Under 37 C.F.R. Section 42.8 Download |
Jun 12, 2018 | 9 | | Trial Instituted Document Download |
Jul 12, 2018 | 10 | | Petitioner Mylan Technologies, Inc.'s Request for Rehearing Download |
Jul 20, 2018 | 11 | | Patent Owner Opposition to Request for Rehearing Download |
Sep 5, 2018 | 12 | | Joint Motion to Terminate Proceedings Download |
Sep 5, 2018 | 13 | | Joint Request to Treat Binding Term Sheet (EX2024) as Business Confidential Information Download |
Sep 5, 2018 | 14 | | Patent Owner's Updated Exhibit List as of September 5, 2018 Download |
Sep 13, 2018 | 15 | | DECISION Granting Joint Motion to Terminate Proceeding
35 U.S.C. § 317; 37 C.F.R. §§ 42.72, 42.74 Download |
Sep 26, 2018 | 16 | | Joint Motion to Expunge Exhibit 2024 Under 37 C.F.R. Section 42.56 Download |
Sep 28, 2018 | 17 | | Order - 37 C.F.R. 42.5 Download |
Oct 26, 2018 | 18 | | Petitioner's Request for Refund Download |
Nov 23, 2018 | 19 | | Notice of Refund Download |
Dec 4, 2017 | 1001 | | EX1001 U.S. Patent No. 9,724,310 to Mantelle Download |
Dec 4, 2017 | 1002 | | EX1002 Declaration of Keith Brain, Ph.D Download |
Dec 4, 2017 | 1003 | | EX1003 Brain CV Download |
Dec 4, 2017 | 1004 | | EX1004 US 9,724,310 File History Part 1 of 2 Download |
Dec 4, 2017 | 1004 | | EX1004 US 9,724,310 File History Part 2 of 2 Download |
Dec 4, 2017 | 1004 | | EX1004 US 9,724,310 File History Part 1 of 2 Download |
Dec 4, 2017 | 1005 | | EX1005 US Pat Pub 20030099695 to Mueller Download |
Dec 4, 2017 | 1006 | | EX1006 Vivelle-Dot Label FOI Affidavit and Doc 5236149B Download |
Dec 4, 2017 | 1007 | | EX1007 US Pat Pub 20060078602 to Kanios Download |
Dec 4, 2017 | 1008 | | EX1008 Vivelle Label FOI Affidavit and Doc 5210567A Download |
Dec 4, 2017 | 1009 | | EX1009 US Patent No. 5,145,682 to Chien Download |
Dec 4, 2017 | 1010 | | EX1010 Kim Download |
Dec 4, 2017 | 1011 | | EX1011 US Patnt No. 5,656,286 to Miranda Download |
Dec 4, 2017 | 1012 | | EX1012 WO 1996003119 to Fotinos Download |
Dec 4, 2017 | 1013 | | EX1013 US Patent No. 5,919,477 to Bevan Download |
Dec 4, 2017 | 1014 | | EX1014 Ghosh Download |
Dec 4, 2017 | 1015 | | EX1015 Climara - Document #5243107A Download |
Dec 4, 2017 | 1016 | | EX1016 Alora - Document #5210490A Download |
Dec 4, 2017 | 1017 | | EX1017 Menostar - Document #5228320A Download |
Dec 4, 2017 | 1018 | | EX1018 US Patent No. 5,902,602 to Muller Download |
Dec 4, 2017 | 1019 | | EX1019 US Patent No. 6,156,335 to Rovati Download |
Dec 4, 2017 | 1020 | | EX1020 US Patent No. 6,521,250 to Meconi Download |
Dec 4, 2017 | 1021 | | EX1021 US Patent No. 5,227,169 to Heiber Download |
Dec 4, 2017 | 1022 | | EX1022 Bucks Download |
Dec 4, 2017 | 1023 | | EX1023 Dinger - Noven Pharmaceuticals, Inc Download |
Dec 4, 2017 | 1024 | | EX1024 Butschhli - Tiny Patch 'Dots' Pharmaceutical Landscape Download |
Dec 4, 2017 | 1025 | | EX1025 van der Bijl Download |
Dec 4, 2017 | 1026 | | EX1026 Bronaugh Download |
Dec 4, 2017 | 1027 | | EX1027 US Patent No. 5,352,457 to Jenkins Download |
Dec 4, 2017 | 1028 | | EX1028 US Patent No. 5,603,947 to Wong Download |
Dec 4, 2017 | 1030 | | EX1030 US Patent No. 6,638,528 to Kanios Download |
Dec 4, 2017 | 1031 | | EX1031 US Patent No. 4,624,665 to Nuwayser Download |
Dec 4, 2017 | 1032 | | EX1032 US Pat Pub 20090041831 to Miller Download |
Dec 4, 2017 | 1033 | | EX1033 US Patent No. 6,024,976 to Miranda Download |
Dec 4, 2017 | 1034 | | EX1034 The Orange Book Download |
Dec 4, 2017 | 1035 | | EX1035 US 9,730,900 File History Part 2 of 2 Download |
Dec 4, 2017 | 1035 | | EX1035 US 9,730,900 File History Part 1 of 2 Download |
Dec 4, 2017 | 1035 | | EX1035 US 9,730,900 File History Part 1 of 2 Download |
Dec 4, 2017 | 1036 | | EX1036 US 9,730,900 to Mantelle Download |
Mar 13, 2018 | 2001 | | Declaration of Dr. Adrian C. Williams Download |
Mar 13, 2018 | 2002 | | Curriculum Vitae of Dr. Adrian C. Williams Download |
Mar 13, 2018 | 2003 | | Minivelle¿¿ Product Label Download |
Mar 13, 2018 | 2004 | | J. Hadgraft and R. Guy, Feasibility Assessment in Topical and Transdermal Delivery Download |
Mar 13, 2018 | 2005 | | J. Hadgraft, Passive enhancement strategies in topical and transdermal drug delivery Download |
Mar 13, 2018 | 2006 | | B. Barry, Transdermal Drug Delivery Download |
Mar 13, 2018 | 2007 | | A. Williams & B. Barry, Urea analogues in propylene glycol as penetration enhancers in human skin Download |
Mar 13, 2018 | 2008 | | K. Brain & R. Chilcott, Physicochemical Factors Affecting Skin Absorption Download |
Mar 13, 2018 | 2009 | | Esclim Product Label Download |
Mar 13, 2018 | 2010 | | J. Mantelle, et al., Effect of Silicone/Acrylic PSA Blends on Skin Permeation Download |
Mar 13, 2018 | 2011 | | A. Williams & B. Barry, Chemical Permeation Enhancement Download |
Mar 13, 2018 | 2012 | | A. Williams & B. Barry, The enhancement index concept applied to terpene penetration enhancers for human skin and model lipophilic (oestradiol) and hydrophilic (5-fluorouracil) drugs Download |
Mar 13, 2018 | 2013 | | K. Walters & K. Brain, Dermatological Formulation and Transdermal Systems Download |
Mar 13, 2018 | 2014 | | Google Scholar search results obtained March 7, 2018 ¿¿¿ citations of Kim et al., Penetration Enhancement of ¿¿2-Selective Agonist, Tulobuterol, Across Hairless Mouse Skin Download |
Mar 13, 2018 | 2015 | | A. Ghosh et al., Current Pharmaceutical Design on Adhesive Based Transdermal Drug Delivery Systems Download |
Mar 13, 2018 | 2016 | | U.S. Patent No. 8,029,820 Download |
Mar 13, 2018 | 2017 | | B. Godin & E. Touitou, Transdermal skin delivery: Predictions for humans from in vivo, ex vivo and animal models Download |
Mar 13, 2018 | 2018 | | R. Hinz et al., In vitro percutaneous penetration: evaluation of the utility of hairless mouse skin Download |
Mar 13, 2018 | 2019 | | J. Bond & B. Barry, Hairless mouse skin is limited as a model for assessing the effects of penetration enhancers in human skin Download |
Mar 13, 2018 | 2020 | | R. Subedi et al., Influence of formulation variable in transdermal drug delivery system containing zolmitriptan Download |
Mar 13, 2018 | 2021 | | R. Subedi et al., Formulation and in vitro evaluation of transdermal drug delivery system for donezil Download |
Mar 13, 2018 | 2022 | | J. Mantelle, DOT Matrix Technology Download |
Mar 13, 2018 | 2023 | | J. van de Sandt et al., In vitro predictions of skin absorption of caffeine, testosterone, and benzoic acid: a multi-centre comparison study Download |